Ignacio Jesús Dávila González-rekin lankidetzan egindako argitalpenak (7)

2023

  1. Correspondence regarding the paper “Laorden D, Zamarrón E, Romero D, Domínguez-Ortega J, Villamañán E, Losantos I, Gayá F, Quirce S, Álvarez-Sala R. Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R. Respir. Med. 2023; 211: 107216”

    Respiratory Medicine

  2. Quantitative and qualitative methods of evaluating response to biologics in severe asthma patients: Results from a real-world study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 3, pp. 949-951.e2

  3. RNY3 modulates cell proliferation and IL13 mRNA levels in a T lymphocyte model: a possible new epigenetic mechanism of IL-13 regulation

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 1, pp. 59-69

  4. Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature

    International Journal of Immunopathology and Pharmacology, Vol. 37

  5. Transcriptomics reveals new regulatory mechanisms involved in benralizumab response

    Allergy: European Journal of Allergy and Clinical Immunology

2022

  1. Effects of Therapeutic Antibodies on Gene and Protein Signatures in Asthma Patients: A Comparative Systematic Review

    Biomedicines, Vol. 10, Núm. 2

2021

  1. PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma

    Journal of Personalized Medicine, Vol. 11, Núm. 9